| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |